U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 0.1% on Tuesday.
Shares of Acelyrin, Inc. SLRN fell sharply in today’s pre-market trading.
ACELYRIN announced additional Phase 2 data and the Phase 3 program design for lonigutamab in Thyroid Eye Disease.
Acelyrin shares tumbled 15.4% to $2.95 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Cogent Biosciences, Inc. COGT shares fell 13.2% to $7.00 in pre-market trading.
- ZJK Industrial Co., Ltd. ZJK fell 12.2% to $10.55 in pre-market trading after jumping 32% on Monday.
- Alpha Teknova, Inc. TKNO dipped 7.3% to $8.40 in pre-market trading following a 4% gain on Monday.
- Third Harmonic Bio, Inc. THRD fell 6.8% to $10.41 in pre-market trading.
- Y-mAbs Therapeutics, Inc. YMAB fell 3.7% to $7.52 in pre-market trading.
- NeuroPace, Inc. NPCE fell 4.8% to $11.36 in pre-market trading.
- Tesla, Inc. TSLA fell 1.7% to $404.26 in pre-market trading. Tesla on Monday reminisced about delivering the first Model 3 cars made at the company’s gigafactory in Shanghai.
Now Read This:
- Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Financial Market Newsflash
No financial news published today. Check back later.